• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Routine Mass Spectrometry in Clinical Labs: A Competitive Advantage?

Routine Mass Spectrometry in Clinical Labs: A Competitive Advantage?

by Rachel Muenz | Mar 31, 2025 | Essential, Lab Industry Advisor, Operations-lca

How a new automated system bringing MS to routine lab testing could help set laboratories apart from their competitors

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Which Test? Choosing the Best Approach to Diagnosing Rare Disease

Which Test? Choosing the Best Approach to Diagnosing Rare Disease

by Michael Schubert, PhD | Sep 28, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Testing Trends-dtet

Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Three Common PGx Compliance Traps for Laboratories to Avoid

Three Common PGx Compliance Traps for Laboratories to Avoid

by Adam Walters | Aug 5, 2021 | Blog, Open Content

While the PGx test is a highly valuable form of medical test, it is also presently one of the most highly scrutinized tests by CMS.

CDC Updates Guidelines on Laboratory Testing for Sexually Transmitted Infections

CDC Updates Guidelines on Laboratory Testing for Sexually Transmitted Infections

by Glenn S. Demby | Aug 2, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Three Common PGx Compliance Traps for Laboratories to Avoid

New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening

by Glenn S. Demby | Aug 2, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Testing Trends-dtet

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com